Invesco holds 6.2% of Charles River Labs
Invesco Ltd., a Bermuda-based parent holding company, reports a significant passive ownership position in Charles River Laboratories International, Inc. common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Invesco Ltd., a Bermuda-based parent holding company, reports a significant passive ownership position in Charles River Laboratories International, Inc. common stock. Invesco may be deemed to beneficially own 2,984,785 shares, representing 6.2% of the outstanding common stock, held of record by its investment advisory clients.
Invesco has sole voting power over 2,955,113 shares and sole dispositive power over 2,984,785 shares, with no shared voting or dispositive power. The filing notes that no single underlying client has more than 5% economic ownership of Charles River’s common stock; the relevant clients receive dividends and sale proceeds. Subsidiaries involved include Invesco Advisers, Inc., Invesco Asset Management Limited, and Invesco Capital Management LLC.
Key Figures
Key Terms
beneficially own financial
Sole power to vote financial
dispositive power financial
parent holding company financial
Investment Company Act of 1940 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What ownership stake in CRL does Invesco Ltd. report in this Schedule 13G?
Do any individual Invesco clients hold more than 5% of CRL stock?
What class of Charles River Laboratories securities does this 13G cover?
AI-generated analysis. How Rhea-AI works. Not financial advice.